THC Therapeutics, Inc. financial data

Symbol
THCT on OTC
Location
Las Vegas, NV
Fiscal year end
31 July
Latest financial report
10-K - Q2 2024 - 27 Feb 2026

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 0.27% % -26%
Debt-to-equity -98% % 0.45%
Return On Assets -6632% % -354%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 40,266,149 shares
Common Stock, Shares, Outstanding 40,266,149 shares 18%
Common Stock, Value, Issued $40,266 USD 18%
Weighted Average Number of Shares Outstanding, Basic 38,334,816 shares 17%

Income Statement

Label TTM Value / Value Unit Change %
Revenues $0 USD
Cost of Revenue $0 USD
General and Administrative Expense $240,795 USD 242%
Operating Income (Loss) $541,975 USD -9.7%
Net Income (Loss) Attributable to Parent $811,562 USD -110%
Earnings Per Share, Basic 0 USD/shares

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value $35 USD -100%
Assets, Current $35,000 USD 3471%
Assets $10,648 USD -18%
Liabilities, Current $3,812,203 USD 15%
Liabilities $3,812,203 USD 15%
Retained Earnings (Accumulated Deficit) $39,235,507 USD -2.1%
Stockholders' Equity Attributable to Parent $3,801,555 USD -15%
Liabilities and Equity $10,648 USD -18%

Popular Metrics

Label TTM Value / Value Unit Change %
Common Stock, Shares Authorized 500,000,000 shares 0%
Common Stock, Shares, Issued 40,266,149 shares 18%
Common Stock, Par or Stated Value Per Share 0.001 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $35 USD 250%
Deferred Tax Assets, Valuation Allowance $8,239,456 USD 2.1%
Deferred Tax Assets, Gross $8,239,456 USD 2.1%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 6,983,500 shares 0%
Additional Paid in Capital $41,906,132 USD 1.4%
Preferred Stock, Shares Outstanding 0 shares
Deferred Tax Assets, Net of Valuation Allowance $0 USD
Interest Expense $144,143 USD 81%
Preferred Stock, Par or Stated Value Per Share 0.001 USD/shares -90%